Syndax Pharmaceuticals (SNDX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Syndax Pharmaceuticals (SNDX) is Neutral.

The composite score behind that read is -0.06, weighing +0.23 of bullish evidence against -0.22 bearish.

Syndax Pharmaceuticals last closed at $16.99, +0.53% on the session.

Against the IVW growth benchmark the position is -0.27% over the forecast window.

The read is built from 15 underlying insights — 4 bullish and 11 bearish.

Agreement across those insights is 73%.

Syndax Pharmaceuticals has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Syndax Pharmaceuticals in the 3rd percentile on return on equity, where 100 is best.

Syndax Pharmaceuticals is classified under Health Care / Biotechnology, with a market capitalisation of $1.51B.

StockMap tracks Syndax Pharmaceuticals as the 110th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Syndax Pharmaceuticals ranks 178th of 381 in the group, against a group median of -0.08.